APA (7th ed.) Citation

Banda, C., Dzinjalamala, F., Mukaka, M., Mallewa, J., Maiden, V., Terlouw, D., . . . Mwapasa, V. (2018). Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in falciparum-negative HIV-infected Malawian adults stabilized on antiretroviral therapy. American Society for Microbiology.

Chicago Style (17th ed.) Citation

Banda, CG, F. Dzinjalamala, M. Mukaka, J. Mallewa, V. Maiden, DJ Terlouw, DG Lalloo, SH Khoo, and V. Mwapasa. Impact of Efavirenz, Ritonavir-boosted Lopinavir and Nevirapine Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-lumefantrine in Falciparum-negative HIV-infected Malawian Adults Stabilized on Antiretroviral Therapy. American Society for Microbiology, 2018.

MLA (9th ed.) Citation

Banda, CG, et al. Impact of Efavirenz, Ritonavir-boosted Lopinavir and Nevirapine Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-lumefantrine in Falciparum-negative HIV-infected Malawian Adults Stabilized on Antiretroviral Therapy. American Society for Microbiology, 2018.